| Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ... The Lancet 395 (10241), 1907-1918, 2020 | 1819 | 2020 |
| Randomized phase III trial of pegvorhyaluronidase alfa with nab-paclitaxel plus gemcitabine for patients with hyaluronan-high metastatic pancreatic adenocarcinoma E Van Cutsem, MA Tempero, D Sigal, DY Oh, N Fazio, T Macarulla, ... Journal of Clinical Oncology 38 (27), 3185, 2020 | 282 | 2020 |
| Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium P Grivas, AR Khaki, TM Wise-Draper, B French, C Hennessy, CY Hsu, ... Annals of oncology 32 (6), 787-800, 2021 | 281 | 2021 |
| A phase II basket trial of dual anti–CTLA-4 and anti–PD-1 blockade in rare tumors (DART SWOG 1609) in patients with nonpancreatic neuroendocrine tumors SP Patel, M Othus, YK Chae, FJ Giles, DE Hansel, PP Singh, A Fontaine, ... Clinical Cancer Research 26 (10), 2290-2296, 2020 | 264 | 2020 |
| Total neoadjuvant therapy vs standard therapy in locally advanced rectal cancer: a systematic review and meta-analysis A Kasi, S Abbasi, S Handa, R Al-Rajabi, A Saeed, J Baranda, W Sun JAMA network open 3 (12), e2030097-e2030097, 2020 | 223 | 2020 |
| Cancer chemotherapy MT Amjad, A Chidharla, A Kasi | 191 | 2020 |
| Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19 MA Thompson, JP Henderson, PK Shah, SM Rubinstein, MJ Joyner, ... JAMA oncology 7 (8), 1167-1175, 2021 | 169 | 2021 |
| Similar response rates and survival with PARP inhibitors for patients with solid tumors harboring somatic versus Germline BRCA mutations: a Meta-analysis and systematic review GR Mohyuddin, M Aziz, A Britt, L Wade, W Sun, J Baranda, R Al-Rajabi, ... BMC cancer 20, 1-9, 2020 | 60 | 2020 |
| Association of active oncologic treatment and risk of death in cancer patients with COVID-19: a systematic review and meta-analysis of patient data R Park, SA Lee, SY Kim, AC de Melo, A Kasi Acta Oncologica 60 (1), 13-19, 2021 | 55 | 2021 |
| COVID-19 and Cancer Consortium NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ... Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study …, 2020 | 55 | 2020 |
| Metastatic tumor-in-a-dish, a novel multicellular organoid to study lung colonization and predict therapeutic response P Ramamoorthy, SM Thomas, G Kaushik, D Subramaniam, KM Chastain, ... Cancer research 79 (7), 1681-1695, 2019 | 55 | 2019 |
| Anthracyclines P Venkatesh, A Kasi | 54 | 2019 |
| Lung metastasis A Jamil, A Kasi | 51 | 2020 |
| Immune therapeutics in the treatment of advanced gastric and esophageal cancer R Park, S Williamson, A Kasi, A Saeed Anticancer Research 38 (10), 5569-5580, 2018 | 50 | 2018 |
| Racial disparities in COVID-19 outcomes among black and white patients with cancer J Fu, SA Reid, B French, C Hennessy, C Hwang, NT Gatson, N Duma, ... JAMA network open 5 (3), e224304-e224304, 2022 | 46 | 2022 |
| Association between androgen deprivation therapy and mortality among patients with prostate cancer and COVID-19 AL Schmidt, MD Tucker, Z Bakouny, C Labaki, CY Hsu, Y Shyr, ... JAMA network open 4 (11), e2134330-e2134330, 2021 | 38 | 2021 |
| Sex-bias in COVID-19-associated illness severity and mortality in cancer patients: a systematic review and meta-analysis R Park, A Chidharla, K Mehta, W Sun, E Wulff-Burchfield, A Kasi EClinicalMedicine 26, 2020 | 38 | 2020 |
| Early detection of pancreatic cancers in liquid biopsies by ultrasensitive fluorescence nanobiosensors M Kalubowilage, O Covarrubias-Zambrano, AP Malalasekera, SO Wendel, ... Nanomedicine: Nanotechnology, Biology and Medicine 14 (6), 1823-1832, 2018 | 33 | 2018 |
| Familial adenomatous polyposis S Carr, A Kasi | 30 | 2019 |
| Leptomeningeal carcinomatosis A Batool, A Kasi StatPearls [Internet], 2023 | 29 | 2023 |
